Social media

Therapeutic developers can reshape the future of HIV control by creating interventions that are effective despite persistent real-world challenges. Discover what developers need to take into consideration to make a real-...

Because existing HIV therapies are already highly effective when taken as prescribed, traditional trial settings often fail to reveal the added value of emerging approaches. Explore how developers can plan trials that ...

Meet ICON’s experts at #ASH25, booth \#2161 to discuss how our extensive testing capabilities, clinical research experience and scientific expertise can support global oncology and haematology research programmes. https:...

Tomorrow, 6 December, is the final day of the SCDM #INDIA25! ICON’s experts have been sharing insights in sessions covering clinical trials and data management, regulatory affairs, biotech and pharma partnerships, real-w...

While RWD and tokenisation introduce many efficiencies and benefits to long-term follow-up, there are also extremely stringent requirements for handling the associated data. Find out how to ensure secure long-term foll...

While RWD and tokenisation introduce many efficiencies and benefits to long-term follow-up, there are also extremely stringent requirements for handling the associated data. Find out how to ensure secure long-term foll...

Reaching the right audience is a critical decision. Use the system that does the work for you. Journals & Congresses helps you compare your options on the data points most important to you in making your decision. Get a ...

Reaching the right audience is a critical decision. Use the system that does the work for you. Journals & Congresses helps you compare your options on the data points most important to you in making your decision. Get a ...

Central laboratories are under more pressure than ever. Increasingly complex protocols, frequent amendments, and growing data demands require speed, agility, and uncompromising scientific integrity. At ICON Laboratories,...

Customer advocacy is not a trend, it’s a transformation. It represents a shift from service to stewardship and from expertise to empathy. It’s about recognising that behind every clinical milestone, every regulatory subm...

In the dynamic world of life sciences, the consultancy sector is undergoing a transformation as cost pressures increase, speed to market needs accelerate and technology permeates every aspect. Against this backdrop, cl...

Cardiovascular outcomes trials (CVOTs) are essential for demonstrating clinical value and meeting regulatory expectations but they’re also complex and resource-intensive. On December 8-10, connect with ICON experts at CV...